Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Povidone-iodine** is a topical broad-spectrum antiseptic consisting of iodine complexed with polyvinylpyrrolidone. In the Nantes University Hospital MRSAD-PVP-I study, it was evaluated as a complete transient decolonization kit for adults colonized with methicillin-resistant *Staphylococcus aureus*, comprising a nasal gel, antiseptic body soap, and oral mouthwash. Free iodine released from the complex acts nonselectively on microbial cellular constituents, causing rapid oxidative damage to proteins, nucleic acids, membrane components, and other essential macromolecules. The Phase 2 study, NCT05696132, evaluated decolonization efficacy and acceptability as an alternative to mupirocin plus chlorhexidine and was terminated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on povidone-iodine (Nantes University Hospital).